GSDMD Antikörper
-
- Target Alle GSDMD Antikörper anzeigen
- GSDMD (Gasdermin D (GSDMD))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser GSDMD Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity Purified
- Klon
- R06-5C5
- Isotyp
- IgG
- Top Product
- Discover our top product GSDMD Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 300 μg/mL
- Buffer
- 50 mM Tris-Glycine( pH 7.4), 0.15M NaCl, 40 % Glycerol, 0.01 % Sodium azide and 0.05 % BSA
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- GSDMD (Gasdermin D (GSDMD))
- Andere Bezeichnung
- GSDMD (GSDMD Produkte)
- Hintergrund
- DF5L,DFNA5L,FKSG10,GSDMDC1,GSDMD,GSDMD is a member of the gasdermin family. Members of this family appear to play a role in regulation of epithelial proliferation. GSDMD has been suggested to act as a tumor suppressor. Recently,GSDMD is identified as a new component of inflammasomes,and it is an executor of pyroptosis and required for interleukin-1β secretion. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.
- Molekulargewicht
-
Observed_MW: 53kDa
Calculated_MW: 53kDa
- Gen-ID
- 79792
- UniProt
- P57764
- Pathways
- Inflammasome
-